Strand Therapeutics
Kendall Dionne is a Senior Scientist at Strand Therapeutics since November 2022, specializing in Analytical Operations. Previous experience includes roles as a Scientist at Strand Therapeutics and an Associate Scientist at NextRNA Therapeutics, focusing on the characterization of small molecules and their effects on protein and NK cell expression. Prior positions include Senior Associate Scientist II and I at bluebird bio, where responsibilities encompassed routine analytics and assay development, and a Scientific Associate at Seqirus, characterizing influenza viruses. Early career experiences include a Research Technician at The Ragon Institute and various roles in customer service and team management. Kendall Dionne holds a B.S. in Biochemistry from the University of New Hampshire.
This person is not in the org chart
Strand Therapeutics
3 followers
Strand was started by biological engineers working together at MIT. Building on the idea of creating smart therapies that are capable of making sophisticated decisions, they sought to apply the concept of the emerging field of mRNA therapeutics.